Global Oxygen Therapy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Oxygen Therapy Market Overview

The Oxygen Therapy Market was valued at USD 49.77 billion in 2025 and is projected to reach USD 110.06 billion by 2033, growing at a CAGR of 10.43% from 2026 to 2033. The Oxygen Therapy Market is experiencing steady growth driven by the rising prevalence of respiratory diseases, increasing geriatric population, and growing demand for home healthcare solutions. Technological advancements in oxygen delivery systems, including portable oxygen concentrators and smart oxygen monitoring devices, are further supporting market expansion across hospitals, clinics, and homecare settings.

The increasing incidence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and pneumonia, coupled with growing awareness regarding early disease management, is encouraging healthcare providers and patients to adopt oxygen therapy solutions. In addition, rising healthcare expenditure, expanding access to respiratory care services, and the growing preference for home-based treatment are accelerating the adoption of oxygen therapy devices worldwide. Portable and user-friendly oxygen delivery systems are increasingly replacing traditional stationary equipment in many markets, offering greater convenience, mobility, and improved quality of life for patients requiring long-term oxygen support.

Key Market Trends & Insights

• North America dominated the Oxygen Therapy Market with the largest revenue share of 36.24% in 2025, supported by a high prevalence of chronic respiratory diseases, advanced healthcare infrastructure, favorable reimbursement policies, and strong adoption of home healthcare solutions. The region also benefits from increasing demand for portable oxygen concentrators and continuous investments in respiratory care technologies.
• The Oxygen Source Equipment segment dominated the market with a 57.18% share in 2025 owing to its critical role in generating, storing, and supplying medical oxygen across hospitals, clinics, rehabilitation centers, and home healthcare settings.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.8% from 2026 to 2033, fueled by rising air pollution levels, increasing prevalence of respiratory diseases, expanding healthcare infrastructure, growing geriatric population, and improving access to respiratory care services across China, India, and Japan.
• The Oxygen Delivery Devices segment is the fastest-growing product category, projected to register a CAGR of 7.4%, reflecting increasing demand for advanced oxygen masks, nasal cannulas, and high-flow oxygen therapy systems that enhance patient comfort and treatment efficiency.
• The Respiratory Disorder segment dominates the disease type category with a 48.63% revenue share in 2025, led by the growing global burden of chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and other respiratory conditions requiring supplemental oxygen therapy.
• Home Healthcare accounts for 44.27% of the market, driven by increasing preference for home-based treatment, rising adoption of portable oxygen concentrators, growing elderly population, and efforts to reduce hospital admissions and healthcare costs through remote patient management.
• The Home Healthcare segment is also the fastest-growing end-user category, with a CAGR of 7.6%, supported by advancements in portable oxygen delivery technologies, increasing patient preference for convenient long-term care, and expanding availability of home respiratory therapy services worldwide.

Market Size & Forecast

• Global Market Value (2025): USD 49.77 Billion
• Expected Market Value (2033): USD 110.06 Billion
• Forecast CAGR (2026–2033): 10.43%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia-Pacific

Report Scope and Oxygen Therapy Market Segmentation

Oxygen Therapy Market Trends

Trend: Rising Demand for Home-Based and Portable Oxygen Therapy

The oxygen therapy market is witnessing strong growth in home healthcare and portable oxygen delivery solutions, driven by the increasing prevalence of chronic respiratory diseases such as COPD, asthma, pulmonary fibrosis, and obstructive sleep apnea. Patients are increasingly preferring home-based treatment due to greater convenience, lower healthcare costs, and improved quality of life. Technological advancements in portable oxygen concentrators (POCs) are further supporting this trend by enabling continuous oxygen support while maintaining patient mobility. For instance, in October 2024, Inogen launched the Rove 4 Portable Oxygen Concentrator, capable of delivering up to 840 ml/min of medical-grade oxygen in a lightweight device weighing less than 3 pounds, reflecting the industry's focus on portability and patient-centric care. Additionally, the global home healthcare sector surpassed USD 392 billion in 2023, creating a favorable environment for the adoption of home oxygen therapy solutions.

Oxygen Therapy Market Dynamics

Key Market Driver: Increasing Burden of Chronic Respiratory Diseases

The growing prevalence of respiratory disorders remains the primary driver of the Oxygen Therapy Market. Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia, and sleep apnea continue to create substantial demand for supplemental oxygen across hospitals, clinics, and home-care settings. According to the World Health Organization (WHO), COPD causes approximately 3 million deaths annually worldwide and affects hundreds of millions of individuals, making oxygen therapy a critical component of disease management. Furthermore, the oxygen therapy market was valued at approximately USD 34.8 billion in 2023 and is projected to exceed USD 54 billion by 2030, supported by the expanding patient pool and increasing adoption of long-term oxygen therapy.

 Key Restraint/Challenge: High Cost of Advanced Oxygen Therapy Equipment and Infrastructure

A major challenge for market growth is the significant cost associated with advanced oxygen therapy equipment and supporting infrastructure. Portable oxygen concentrators, liquid oxygen systems, oxygen generation plants, and hospital-based oxygen delivery networks require considerable capital investment, regular maintenance, and periodic technology upgrades. This financial burden can limit adoption, particularly in smaller healthcare facilities and low- and middle-income countries. According to WHO assessments, fewer than half of healthcare facilities in many developing regions have uninterrupted access to medical oxygen, highlighting persistent affordability and infrastructure challenges. The complexity of oxygen production, storage, distribution, and maintenance further increases total ownership costs and constrains broader market penetration.

Key Market Opportunity: Expansion of Smart and Connected Oxygen Therapy Solutions

The integration of digital health technologies into oxygen therapy systems presents a significant growth opportunity. Manufacturers are increasingly developing smart oxygen concentrators equipped with remote monitoring, real-time oxygen saturation tracking, predictive maintenance capabilities, and telehealth connectivity. These innovations enable healthcare providers to monitor patients remotely, optimize therapy compliance, and reduce hospital readmissions. Growing adoption of home healthcare services, coupled with advancements in lightweight portable concentrators and AI-enabled patient monitoring platforms, is expected to accelerate demand across both developed and emerging markets. The continued launch of advanced portable devices such as Inogen's Rove 4 demonstrates the industry's shift toward connected, patient-friendly oxygen therapy solutions that improve mobility, treatment adherence, and overall clinical outcomes.

Oxygen Therapy Market Scope

The Oxygen Therapy market is segmented on the basis of product, disease type, and end user.

• By Product

On the basis of product, the Oxygen Therapy Market is segmented into Oxygen Source Equipment and Oxygen Delivery Devices. The Oxygen Source Equipment segment dominated the market with a 57.18% share in 2025 owing to its critical role in generating, storing, and supplying medical oxygen across hospitals, clinics, rehabilitation centers, and home healthcare settings. This segment includes oxygen concentrators, liquid oxygen systems, and oxygen cylinders, which are widely used for both acute and chronic respiratory care. Rising prevalence of chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and other respiratory disorders has significantly increased demand for oxygen source equipment globally. The growing geriatric population, which is more susceptible to respiratory illnesses, is further supporting segment growth. In addition, technological advancements in portable oxygen concentrators, improved energy efficiency, and enhanced patient mobility are driving adoption. Increasing healthcare expenditure and expanding access to respiratory care services across emerging economies are also contributing to market expansion. The widespread use of oxygen concentrators in home healthcare settings further reinforces the dominance of this segment.

The Oxygen Delivery Devices segment is projected to register the fastest growth at a CAGR of 7.4% from 2026 to 2033, driven by increasing demand for efficient and patient-friendly oxygen administration systems. This segment includes nasal cannulas, oxygen masks, venturi masks, non-rebreather masks, and high-flow oxygen therapy devices. Healthcare providers are increasingly adopting advanced oxygen delivery systems that improve patient comfort, oxygen utilization efficiency, and clinical outcomes. Rising hospitalization rates associated with respiratory disorders and growing use of high-flow oxygen therapy in critical care settings are accelerating demand. In addition, continuous product innovations focused on lightweight designs, improved oxygen flow regulation, and infection control are supporting segment growth. Expanding home-based oxygen therapy programs and increasing awareness regarding respiratory disease management are further contributing to adoption. The growing shift toward personalized respiratory care solutions is expected to drive substantial growth throughout the forecast period.

• By Disease Type

On the basis of disease type, the Oxygen Therapy Market is segmented into Respiratory Disorder, Cardiovascular Disease, Pneumonia, Sleep Apnea, and Others. The Respiratory Disorder segment dominated the market with a 48.63% share in 2025 due to the widespread prevalence of chronic respiratory conditions requiring supplemental oxygen therapy. Diseases such as COPD, asthma, pulmonary fibrosis, emphysema, and chronic bronchitis account for a significant portion of oxygen therapy utilization worldwide. Increasing air pollution levels, smoking prevalence, occupational lung diseases, and aging populations are contributing to the rising burden of respiratory disorders. Healthcare providers increasingly rely on long-term oxygen therapy to improve patient outcomes, reduce hospitalization rates, and enhance quality of life. Technological advancements in oxygen delivery systems and expanding availability of portable oxygen solutions are further supporting adoption. Government initiatives aimed at improving respiratory disease management and increasing awareness regarding early diagnosis also strengthen market growth. The segment continues to benefit from growing healthcare investments and improved access to respiratory care services globally.

The Sleep Apnea segment is projected to witness the fastest CAGR of 7.2% from 2026 to 2033, driven by increasing diagnosis rates and growing awareness of sleep-related breathing disorders. Rising obesity prevalence, sedentary lifestyles, and growing geriatric populations are contributing to a higher incidence of obstructive sleep apnea worldwide. Healthcare providers are increasingly incorporating oxygen therapy and related respiratory support solutions into comprehensive sleep disorder management programs. Advancements in home monitoring technologies and improved diagnostic capabilities are facilitating earlier detection and treatment. In addition, increasing patient preference for home-based care and growing availability of portable respiratory support devices are supporting adoption. Rising healthcare expenditure and expanding sleep medicine infrastructure across emerging markets are also driving segment growth. The growing recognition of untreated sleep apnea as a risk factor for cardiovascular complications is expected to further accelerate demand.

• By End User

On the basis of end user, the Oxygen Therapy Market is segmented into Hospitals, Clinics, Rehab Centers, Home Healthcare, and Non-home Healthcare. The Hospitals segment dominated the market with a 38.84% share in 2025 owing to the high volume of patients requiring oxygen therapy for acute and chronic respiratory conditions. Hospitals remain the primary point of care for patients suffering from severe respiratory disorders, cardiovascular complications, pneumonia, and critical illnesses requiring continuous oxygen support. The availability of advanced respiratory care infrastructure, skilled healthcare professionals, and intensive care facilities supports widespread adoption within hospitals. Increasing hospitalization rates associated with chronic respiratory diseases and aging populations continue to drive demand. In addition, hospitals account for a significant share of emergency oxygen therapy utilization and post-surgical respiratory management. Growing investments in healthcare infrastructure and expansion of critical care facilities further reinforce the segment’s leading position. The increasing adoption of advanced oxygen delivery systems and centralized oxygen supply networks also supports market dominance.

The Home Healthcare segment is projected to register the fastest growth at a CAGR of 7.6% from 2026 to 2033, driven by the growing preference for home-based treatment and long-term respiratory care. Patients with chronic respiratory disorders increasingly prefer receiving oxygen therapy at home due to convenience, reduced healthcare costs, and improved quality of life. The rapid adoption of portable oxygen concentrators and lightweight oxygen delivery devices is making home treatment more accessible and effective. In addition, rising healthcare expenditure, increasing awareness regarding chronic disease management, and advancements in remote patient monitoring technologies are supporting segment expansion. Healthcare systems worldwide are promoting home healthcare models to reduce hospital burden and optimize resource utilization. Expanding reimbursement coverage for home oxygen therapy and growing availability of user-friendly oxygen equipment are further accelerating adoption. The trend toward personalized and patient-centric care is expected to significantly drive growth throughout the forecast period.

Oxygen Therapy Market Regional Analysis

North America dominated the Oxygen Therapy Market and accounted for the largest revenue share of 36.24% in 2025, supported by the high prevalence of chronic respiratory diseases such as COPD, asthma, sleep apnea, and pulmonary fibrosis. The region benefits from advanced healthcare infrastructure, strong reimbursement frameworks, widespread adoption of home healthcare services, and high awareness regarding respiratory disease management. Increasing demand for portable oxygen concentrators, long-term oxygen therapy solutions, and technologically advanced respiratory care devices is further driving market growth. Continuous investments in healthcare innovation and the presence of leading oxygen therapy manufacturers continue to strengthen North America's position in the global market.

U.S. Oxygen Therapy Market Insight

The U.S. Oxygen Therapy market is witnessing robust growth due to the increasing burden of chronic respiratory disorders, a rapidly aging population, and growing preference for home-based healthcare services. The country represents one of the largest markets for portable oxygen concentrators and oxygen delivery systems, supported by favorable reimbursement policies and high healthcare expenditure. Furthermore, rising adoption of connected oxygen therapy devices, remote patient monitoring solutions, and advancements in respiratory care technologies are driving demand across hospitals, long-term care facilities, and homecare settings.

Europe Oxygen Therapy Market Insight

The Europe Oxygen Therapy market remains a significant contributor to global revenue, driven by the growing prevalence of respiratory diseases, expanding geriatric population, and strong government support for respiratory healthcare programs. The region's well-established healthcare infrastructure and increasing focus on home oxygen therapy are supporting market expansion. Rising adoption of portable oxygen concentrators, technological advancements in oxygen delivery systems, and growing awareness regarding chronic respiratory disease management continue to enhance market growth across Europe.

U.K. Oxygen Therapy Market Insight

The U.K. Oxygen Therapy market is experiencing steady growth, supported by increasing incidence of chronic respiratory conditions, growing elderly population, and rising demand for home-based oxygen therapy services. Government initiatives aimed at improving respiratory healthcare outcomes, along with growing adoption of portable and energy-efficient oxygen concentrators, are contributing to market expansion. Additionally, advancements in remote patient monitoring and telehealth services are improving patient access to long-term oxygen therapy solutions throughout the country.

Germany Oxygen Therapy Market Insight

The Germany Oxygen Therapy market is expanding steadily due to the country's advanced healthcare system, strong focus on medical technology innovation, and increasing prevalence of respiratory diseases among its aging population. Hospitals, respiratory care centers, and home healthcare providers are increasingly adopting advanced oxygen delivery systems to improve patient outcomes. Growing investments in healthcare infrastructure, coupled with rising demand for portable oxygen concentrators and home oxygen therapy solutions, continue to drive market growth in Germany.

Asia-Pacific Oxygen Therapy Market Insight

The Asia-Pacific Oxygen Therapy market is expected to witness the fastest growth, registering a CAGR of 7.8% from 2026 to 2033. Growth is driven by rising air pollution levels, increasing prevalence of respiratory diseases, expanding healthcare infrastructure, and a rapidly growing geriatric population across countries such as China, India, and Japan. Improving healthcare access, increasing healthcare expenditure, and growing awareness regarding respiratory disease management are further supporting market expansion. In addition, rising adoption of home healthcare services and increasing availability of affordable oxygen therapy devices are creating significant growth opportunities throughout the region.

Japan Oxygen Therapy Market Insight

The Japan Oxygen Therapy market is witnessing consistent growth due to the country's rapidly aging population and increasing prevalence of chronic respiratory disorders. Strong healthcare infrastructure, high adoption of advanced medical technologies, and growing demand for home-based respiratory care solutions are supporting market development. Furthermore, increasing use of portable oxygen concentrators and digital health technologies for remote patient monitoring is contributing to the expansion of oxygen therapy services across Japan.

China Oxygen Therapy Market Insight

The China Oxygen Therapy market is growing rapidly, driven by rising air pollution, increasing incidence of respiratory diseases, and ongoing expansion of healthcare infrastructure. Government initiatives aimed at improving healthcare accessibility, coupled with growing investments in respiratory care services, are accelerating market growth. Increasing awareness regarding oxygen therapy, rising demand for home healthcare solutions, and growing adoption of portable oxygen concentrators are further positioning China as one of the fastest-growing markets for oxygen therapy in the Asia-Pacific region.

Oxygen Therapy Market Share

The Oxygen Therapy industry is primarily led by well-established companies, including:

• Koninklijke Philips N.V. (Netherlands)
• Invacare Corporation (U.S.)
• Drive DeVilbiss Healthcare (U.S.)
• ResMed Inc. (U.S.)
• CAIRE Inc. (U.S.)
• Inogen, Inc. (U.S.)
• Chart Industries, Inc. (U.S.)
• Nidek Medical Products, Inc. (U.S.)
• Precision Medical, Inc. (U.S.)
• Besco Medical Co., Ltd. (China)
• Yuwell Medical (China)
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
• O2 Concepts, LLC (U.S.)
• Teijin Limited (Japan)
• Linde plc (Ireland)
• Air Liquide S.A. (France)
• GCE Group (Sweden)
• Becton, Dickinson and Company (U.S.)
• Smiths Medical (U.K.)
• Medtronic plc (Ireland)
• Getinge AB (Sweden)
• Allied Healthcare Products, Inc. (U.S.)
• Oxymat A/S (Denmark)
• Longfian Scitech Co., Ltd. (China)
• Shenyang Canta Medical Tech Co., Ltd. (China)
• Molecular Products Group (U.K.)
• Essex Industries, Inc. (U.S.)
• Hersill S.L. (Spain)
• Narang Medical Limited (India)
• BPL Medical Technologies (India)

Latest Developments in Oxygen Therapy Market

• In September 2025, Moog Inc. has unveiled its latest motion systems all electric E60 Series and the electro pneumatic P60 Series, setting a new benchmark for simulation across aviation, land, and maritime training with support for up to 14,000 kg loads and high fidelity motion for Level D flight simulators and other professional uses. The upgraded platforms deliver enhanced reliability, compact design and sustained operational uptime, reflecting modernized electronics and sustainable operation. These new systems strengthen Moog’s market leadership in simulation motion technology by boosting performance, energy efficiency, and usability
• In January 2025, Exail Technologies has acquired Leukos, a French photonics specialist known for pulsed micro lasers, supercontinuum laser sources, ultrafast lasers, and simulation-enabled optical systems, strengthening its technological and industrial capabilities in advanced laser and simulation technologies. The deal integrates Leukos’s expertise with Exail’s photonics, optical, and simulation platforms, broadening product offerings for applications in biophotonics, microelectronics, and high-fidelity training simulations. This strategic acquisition accelerates Exail’s innovation in high-tech technologies, creating synergies that expand its reach in scientific, industrial, and simulation applications while reinforcing its position as a leading advanced-technology provider
• In November 2025, IPG Automotive launched CarMaker 15.0, the latest version of its driving simulation software used for virtual vehicle development. The new release improves simulation accuracy by integrating virtual electronic control units (vECUs), allowing engineers to test software and vehicle systems at earlier development stages. It also includes enhanced sensor models and improved endurance testing capabilities for ADAS and autonomous vehicles. This development strengthens IPG Automotive’s position in the driving simulator market, as CarMaker enables automotive manufacturers to perform complex vehicle tests in a virtual driving environment instead of physical road testing.
• In November 2024, IPG Automotive released CarMaker 14.0, introducing new simulation capabilities including advanced sensor models and more realistic virtual environments. The update allows developers to simulate complex traffic scenarios involving pedestrians, vehicles, and different weather conditions. These features help automotive companies test ADAS and autonomous driving systems more efficiently in driving simulators, reducing development time and cost. The upgrade also expanded simulation capabilities for heavy-duty vehicles using the TruckMaker platform.
• In June 2023, IPG Automotive participated in the UNICARagil research project, collaborating with universities and industry partners to develop automated vehicle architectures. The company contributed its CarMaker driving simulation platform to support simulation and validation of automated driving systems in Software-in-the-Loop (SIL) and Hardware-in-the-Loop (HIL) environments. This collaboration demonstrates the application of Oxygen Therapy in research and development of autonomous mobility solutions

SKU-55646